Inventor · disambiguated record
Stacy Remiszewski
Also filed as: REMISZEWSKI STACY · REMISZEWSKI STACY W · REMISZEWSKI STACY WILLIAM
41 granted patents·8 pending applications·1,384 citations·filing 1995–2022
98Inventor score
Top patents by PatentIndex Score
49 records- 0198US5874442ATricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseaseSCHERING CORP·Filed 1996·Granted Feb 23, 1999·129 cites·7 claims
- 0297US6552065B2Deacetylase inhibitorsNOVARTIS AG·Filed 2001·Granted Apr 22, 2003·338 cites·27 claims
- 0396US6410541B2Compounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 2001·Granted Jun 25, 2002·56 cites·9 claims
- 0496US6387905B2Compounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 2001·Granted May 14, 2002·59 cites·12 claims
- 0594US6228856B1Compounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 1999·Granted May 8, 2001·60 cites·24 claims
- 0694US6211193B1Compounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 1998·Granted Apr 3, 2001·60 cites·16 claims
- 0792US5994364ATricyclic antitumor farnesyl protein transferase inhibitorsSCHERING CORP·Filed 1997·Granted Nov 30, 1999·58 cites·19 claims
- 0892US5719148ATricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Feb 17, 1998·92 cites·47 claims
- 0991US7067551B2Deacetylase inhibitorsNOVARTIS AG·Filed 2004·Granted Jun 27, 2006·36 cites·9 claims
- 1091US6833384B2Deacetylase inhibitorsNOVARTIS AG·Filed 2002·Granted Dec 21, 2004·32 cites·8 claims
- 1190US6576639B1Compounds for the inhibition of farnesyl protein transferaseSCHERING CORP·Filed 2000·Granted Jun 10, 2003·23 cites·19 claims
- 1290US5721236ATricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Feb 24, 1998·72 cites·11 claims
- 1388US6358968B1N-substituted urea inhibitors of farnesyl-protein transferaseSCHERING CORP·Filed 2000·Granted Mar 19, 2002·26 cites·13 claims
- 1487US6075025ATricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1998·Granted Jun 13, 2000·34 cites·8 claims
- 1586US6242458B1Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1999·Granted Jun 5, 2001·25 cites·8 claims
- 1686US5714609ATricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Feb 3, 1998·60 cites·22 claims
- 1785US5696121ATricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Dec 9, 1997·50 cites·6 claims
- 1883US6365588B1Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1999·Granted Apr 2, 2002·22 cites·11 claims
- 1979US6492381B1Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 2000·Granted Dec 10, 2002·7 cites·9 claims
- 2079US5728703ATricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Mar 17, 1998·34 cites·16 claims
- 2178US5807853ATricyclic amide and urea compounds, useful inhibition of g-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Sep 15, 1998·18 cites·22 claims
- 2277US9422331B22-oxo-2,3,4,5-tetrahydro-1 H-benzo[B]diazepines and their use in the treatment of cancerHOFFMANN LA ROCHE·Filed 2013·Granted Aug 23, 2016·2 cites·34 claims
- 2377US5861395ACompounds useful for inhibition of farnesyl proteins transferaseSCHERING CORP·Filed 1997·Granted Jan 19, 1999·22 cites·32 claims
- 2476US11459321B2Broad spectrum antiviral compositions and methodsEVRYS BIO LLC·Filed 2018·Granted Oct 4, 2022·2 cites·21 claims
- 2576US11358961B2Anti-HCMV compositions and methodsEVRYS BIO LLC·Filed 2019·Granted Jun 14, 2022·1 cites·15 claims
- 2676US10556894B2Anti-HCMV compositions and methodsFORGE LIFE SCIENCE LLC·Filed 2015·Granted Feb 11, 2020·2 cites·24 claims
- 2772US6214828B1Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseaseSCHERING CORP·Filed 1998·Granted Apr 10, 2001·22 cites·12 claims
- 2871US12459935B2Broad spectrum antiviral compositions and methodsEVRYS BIO LLC·Filed 2022·Granted Nov 4, 2025·0 cites·19 claims
- 2968US2022135556A1Anti-hcmv compositions and methodsEVRYS BIO LLC·Filed 2022·Application pending·0 cites
- 3067US9403768B2IndolinesHOFFMANN LA ROCHE·Filed 2013·Granted Aug 2, 2016·1 cites·25 claims
- 3165US6277854B1Tricyclic antitumor farnesyl protein transferase inhibitorsSCHERING CORP·Filed 1999·Granted Aug 21, 2001·9 cites·16 claims
- 3264US6030982ACompounds useful for inhibition of farnesyl protein transferaseSCHERING CORPORATIONM·Filed 1997·Granted Feb 29, 2000·10 cites·34 claims
- 3363US2008176849A1Deacetylase inhibitorsREMISZEWSKI STACY WILLIAM·Filed 2008·Application pending·0 cites
- 3458US2006189674A1Deacetylase inhibitorsREMISZEWSKI STACY W·Filed 2006·Application pending·0 cites
- 3557US5939416ABenzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitorsSCHERING CORP·Filed 1997·Granted Aug 17, 1999·13 cites·13 claims
- 3657US2002068742A1Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesFiled 2001·Application pending·0 cites
- 3755US2024109883A1Anti-Tumor Compositions and MethodsEVRYS BIO LLC·Filed 2021·Application pending·0 cites
- 3854US2021040049A1Anti-hcmv compositions and methodsEVRYS BIO LLC·Filed 2020·Application pending·0 cites
- 3951US6143758ATricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1998·Granted Nov 7, 2000·6 cites·13 claims
- 4050US2003055065A1Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesFiled 2001·Application pending·0 cites
- 4148US6699872B2N-substituted urea inhibitors of farnesyl-protein transferaseSCHERING CORP·Filed 2001·Granted Mar 2, 2004·0 cites·8 claims
- 4247US5977128ATricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1997·Granted Nov 2, 1999·2 cites·14 claims
- 4347US2007123580A1Combination of histone deacetylase inhibitors with chemotherapeutic agentsATADJA PETER W·Filed 2004·Application pending·0 cites
- 4446US10723708B2Anti-HCMV compositions and methodsFORGE LIFE SCIENCE LLC·Filed 2015·Granted Jul 28, 2020·0 cites·14 claims
- 4545US9611224B2Antiproliferative benzo [B] azepin-2-onesHOFFMANN LA ROCHE·Filed 2013·Granted Apr 4, 2017·0 cites·42 claims
- 4644US10053431B2Tetrahydro-benzodiazepinonesHOFFMANN LA ROCHE·Filed 2014·Granted Aug 21, 2018·0 cites·4 claims
- 4744US9422332B2Azaheterocycles as BIR2 and/or BIR3 inhibitorsHOFFMANN LA ROCHE·Filed 2013·Granted Aug 23, 2016·0 cites·23 claims
- 4844US9394263B2Substituted hetero-azepinonesHOFFMANN LA ROCHE·Filed 2013·Granted Jul 19, 2016·0 cites·19 claims
- 4942US6300338B1Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1999·Granted Oct 9, 2001·1 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →